Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...

Experiment suggests liver could be key to restarting neural activities, a discovery that could pave the way for new cardiac ...

Metabolic dysfunction-associated steatotic liver disease (MASLD)—previously known as "non-alcoholic fatty liver ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

Last week, BioVie announced a significant milestone: a Notice of Allowance from the Japan Patent Office for its application regarding a novel liquid formulation of terlipressin. This formulation, ...

Ultra-processed food consumption in obese adolescents is linked to insulin resistance and liver disease, stressing the need ...

Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...